By Manju T. Beier, PharmD, CGP, FASCP
Much has been written and discussed regarding polypharmacy, especially in older adults, as well as its increased risk for adverse drug reactions. Over the last two decades, explicit and implicit criteria for potentially inappropriate medications have been developed and implemented to address this worrisome burden. As a recent editorial1 in JAMA Internal Medicine succinctly articulated, the art and science behind systematically discontinuing targeted